PNEUMOVAX 23 25 ug/.5mL
pneumococcal vaccine polyvalent · INJECTION, SOLUTION · Merck Sharp & Dohme LLC
PNEUMOVAX 23 is a injection, solution containing pneumococcal vaccine polyvalent at 25 ug/.5mL, taken intramuscular. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- PNEUMOVAX 23
- Generic Name
- pneumococcal vaccine polyvalent
- NDC Code (Product)
0006-4943- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 25 ug/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA101094
- Marketing Start
- 07/07/1983
Recall History
No Recall HistoryFrequently Asked Questions
What is PNEUMOVAX 23 used for?
PNEUMOVAX 23 contains pneumococcal vaccine polyvalent. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.
Is PNEUMOVAX 23 a controlled substance?
PNEUMOVAX 23 is not classified as a controlled substance by the DEA.
What is the generic name for PNEUMOVAX 23?
The generic name for PNEUMOVAX 23 is pneumococcal vaccine polyvalent. There are no other listed brand versions of pneumococcal vaccine polyvalent.
What is the NDC code for PNEUMOVAX 23 25 ug/.5mL?
The NDC (National Drug Code) for PNEUMOVAX 23 25 ug/.5mL is 0006-4943, listed by Merck Sharp & Dohme LLC.
Other PNEUMOVAX 23 Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)